Show simple item record

dc.contributor.authorBedimo, Roger
dc.contributor.authorChen, Ray Y.
dc.contributor.authorAccortt, Neil A.
dc.contributor.authorRaper, James L
dc.contributor.authorLinn, Carol
dc.contributor.authorAllison, Jeroan J.
dc.contributor.authorDubay, John
dc.contributor.authorSaag, Michael S.
dc.contributor.authorHoesley, Craig J.
dc.date2022-08-11T08:10:43.000
dc.date.accessioned2022-08-23T17:17:36Z
dc.date.available2022-08-23T17:17:36Z
dc.date.issued2004-10-21
dc.date.submitted2010-08-05
dc.identifier.citationClin Infect Dis. 2004 Nov 1;39(9):1380-4. Epub 2004 Oct 11. <a href="http://dx.doi.org/10.1086/424883">Link to article on publisher's site</a>
dc.identifier.issn1058-4838 (Linking)
dc.identifier.doi10.1086/424883
dc.identifier.pmid15494916
dc.identifier.urihttp://hdl.handle.net/20.500.14038/47665
dc.description.abstractIn a comparison of rates of acquired immunodeficiency syndrome (AIDS)-defining malignancies (ADMs) for 1989-1996 versus 1997-2002, we found a decrease in ADMs (rate ratio, 0.31; P<.0001) and a significant increase in non-AIDS-defining malignancies (non-ADMs; rate ratio, 10.87; P<.0002). The mean CD4 cell count was lower among patients with ADMs than among those with non-ADMs. A longer duration of survival during highly active antiretroviral therapy might explain the increasing incidence of non-ADMs.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=15494916&dopt=Abstract">Link to Article in PubMed</a>
dc.rights© 2004 by the Infectious Diseases Society of America.
dc.subjectAdult
dc.subjectAged
dc.subjectAnti-HIV Agents
dc.subjectAntiretroviral Therapy, Highly Active
dc.subjectCD4 Lymphocyte Count
dc.subjectFemale
dc.subjectHIV Infections
dc.subjectHumans
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectNeoplasms
dc.subjectRisk Factors
dc.subjectBioinformatics
dc.subjectBiostatistics
dc.subjectEpidemiology
dc.subjectHealth Services Research
dc.titleTrends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002
dc.typeJournal Article
dc.source.journaltitleClinical infectious diseases : an official publication of the Infectious Diseases Society of America 15937776
dc.source.volume39
dc.source.issue9
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1792&amp;context=qhs_pp&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/qhs_pp/792
dc.identifier.contextkey1426266
refterms.dateFOA2022-08-23T17:17:36Z
html.description.abstract<p>In a comparison of rates of acquired immunodeficiency syndrome (AIDS)-defining malignancies (ADMs) for 1989-1996 versus 1997-2002, we found a decrease in ADMs (rate ratio, 0.31; P<.0001) and a significant increase in non-AIDS-defining malignancies (non-ADMs; rate ratio, 10.87; P<.0002). The mean CD4 cell count was lower among patients with ADMs than among those with non-ADMs. A longer duration of survival during highly active antiretroviral therapy might explain the increasing incidence of non-ADMs.</p>
dc.identifier.submissionpathqhs_pp/792
dc.contributor.departmentDepartment of Quantitative Health Sciences
dc.source.pages1380-4


Files in this item

Thumbnail
Name:
Clinical_infectious_diseases_2 ...
Size:
146.8Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record